Caris Life Sciences Raises 2025 Revenue Guidance After Strong Q3 Results
Caris Life Sciences reported third-quarter 2025 revenue of $216.8 million, a 113% increase from the same period last year, announced in a press release. The company attributed the growth to strong performance in its molecular profiling services.
Caris completed 50,763 clinical therapy selection cases during the quarter, marking an 18.2% increase year-over-year. Gross margin improved to 68.0%, representing a 2,432 basis point increase from the prior year period.
The company reported a net income of $24.3 million and positive adjusted EBITDA of $51.2 million. Operating activities generated $62.4 million in net cash flow, with free cash flow reaching $55.3 million.
Based on its performance, Caris raised its full-year 2025 revenue guidance to a range of $720 million to $730 million, representing expected growth of 75% to 77% compared to 2024.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
HCLTech Advanced AI Revenue Reaches $219 Million in Second Quarter
Heidi Raises $340 Million for Health Care AI Expansion
Basecamp Research Raises $140 Million for AI Designed Therapeutics
ASML Reports Record €11.7 Billion Sales as AI Demand Strains Supply
Synopsys Forecasts 15% Revenue Growth and Plans $1 Billion Buyback
Daily AI Brief: the AI news that matters, in your inbox.